doi: 10.1016/j.medcli.2025.106941
[1] [2] Common adverse effects that women should anticipate include: Gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation) affecting up to 40% of users, typically most pronounced during dose escalation [1] [2] Injection site reactions such as redness or itching Headache and dizziness Fatigue , which might be particularly relevant for women already experiencing tiredness from fibroid-related anaemia Serious but rare risks include pancreatitis (inflammation of the pancreas), gallbladder disease, and hypoglycaemia, particularly in those taking other glucose-lowering medications
The physical demands of seated work are less than the demands of light work, which requires six hours of standing per day
Both Novo and Lilly have signed a handful of deals to build out its future pipelineof GLP-1s specifically and weight loss drug development more broadly
The effect was independent of total calorie intake, suggesting GLP-1 receptor interference plays a primary role
